GRIN disorder
GRIN disorders (also GRIN-related disorders) are a group of neurodevelopmental disorders that result from mutations in genes coding for subunits of an N-methyl-D-aspartate (NMDA) receptor, which leads to dysfunction of glutamate signaling. GRIN disorders are universally characterized by a varying degree of developmental delay and intellectual disability, as well as epileptic seizures. Other clinical features vary depending on the affected gene and may include muscular hypotonia, spasticity, and movement disorders. GRIN disorders are confirmed with genetic testing and managed symptomatically since there is currently no cure for the disorder.
Presentation
Clinical features of GRIN-related disorders typically include intellectual disability and epilepsy along with other neurological and/or neuropsychiatric features, such as movement disorders, autism spectrum disorder, and problems with muscle tone.[1] The table below features some symptoms that can be present in disorders associated with particular genes, but the occurrence and severity of these symptoms are variable. There are only a few cases reported for GRIN2D-related disorder so far; therefore, listed features may not accurately reflect the spectrum of findings in this disorder.[citation needed]
| Feature | GRIN1[2] | GRIN2A[3][4] | GRIN2B[5][clarification needed] | GRIN2D[6] |
|---|---|---|---|---|
| Onset of seizures | Birth to 11 years (median 22.5 months) | Typically from 3 to 6 years | Birth to 9 years (median 3 years) | 1 month to 2 years |
| Epilepsy/seizure type | Focal and/or generalized seizures of various types (e.g., generalized tonic-clonic, atonic, myoclonic seizures, bilateral eyelid myoclonus, gelastic seizures) | Atypical childhood epilepsy with centrotemporal spikes Continuous spikes and waves during slow-wave sleep syndrome Landau-Kleffner syndrome |
Generalized and/or focal Epileptic spasms |
Atonic seizures Generalized tonic-clonic seizures Myoclonic seizures |
| Cognitive symptoms | Typically severe developmental delay and intellectual disability | |||
| Other symptoms | Movement disorders (chorea and/or dystonia) Cortical visual impairment Impaired muscle tone (either hypotonia or, more rarely, spasticity) Cortical visual impairment Oculogyric crisis Scoliosis |
Speech disorders (e.g., aphasia, agnosia, speech dyspraxia) | Autism spectrum disorder Movement disorders (chorea and/or dystonia) Cortical visual impairment Impaired muscle tone (either hypotonia or, more rarely, spasticity) |
Hypotonia Movement disorders (chorea, athetosis) Autism spectrum disorder |
| MRI findings | Diffuse polymicrogyria | Typically normal | Corpus callosum hypoplasia Polymicrogyria Hippocampal dysplasia |
Typically normal |
Pathophysiology
NMDA receptors are a class of ionotropic glutamate receptors. The receptors are clustered at postsynaptic membranes of neurons and are composed of four subunits, which form a pore that allows for the passage of cations, including Ca2+, Na+, and K+. Normally, the pore of the receptor is blocked by Mg2+ in a voltage-dependent manner. Activation of the receptor requires binding of its main agonist, glutamate, as well as its co-agonist, glycine. Upon binding of glutamate and glycine and depolarization of the postsynaptic membrane mediated by another type of ionotropic receptor, AMPA receptor, Mg2+-caused block is relieved. This allows for the passage of Ca2+ and Na+ inside and K+ outside the cell, which leads to further postsynaptic membrane depolarization and activation of multiple downstream signaling pathways. Normal function of NMDA receptors is crucial for neuronal development, synaptic plasticity, learning, and memory.[citation needed]
NMDA receptor is composed of four subunits assembled from seven possible ones (GluN1, GluN2 A to D, and GluN3A and GluN3B).[7] A conventional NMDA receptor includes two GluN1 and two GluN2 subunits. The role of another type of subunits, GluN3, is not yet clear, although both its subtypes (GluN3A and GluN3B) were shown to resemble GluN1 subunits structurally and to assemble with the latter forming a functional receptor.[8] Subunits of NMDA receptor are encoded by GRIN genes:
- GRIN1 codes for GluN1;
- GRIN2A, GRIN2B, GRIN2C, and GRIN2D code for GluN2 A to D;
- GRIN3A and GRIN3B code for GluN3A and GluN3B.
Missense and nonsense variants of these genes can affect the function of the NMDA receptor and potentially lead to a range of neurological and neuropsychiatric sequelae. Variants in GRIN1, GRIN2A, GRIN2B, and GRIN2D were shown to be associated with specific clinical syndromes.[9]
Diagnosis
![[icon]](/wiki/File:Wiki_letter_w_cropped.svg){kind=small} | This section needs expansion. You can help by adding to it. (June 2021) |
Treatment
| This section needs expansion. You can help by adding to it. (June 2021) |
References
- ^ "GRIN Portal". Retrieved June 17, 2021.
- ^ Platzer K, Lemke JR (2019). "GRIN1-Related Neurodevelopmental Disorder". GeneReviews. University of Washington, Seattle. PMID 27683935.
- ^ Lemke JR, Lal D, Reinthaler EM, Steiner I, Nothnagel M, Alber M, et al. (2013). "Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes". Nat Genet. 45 (9): 1067–72. doi:10.1038/ng.2728. PMID 23933819. S2CID 1564780.
- ^ Myers KA, Scheffer IE (2016). "GRIN2A-Related Speech Disorders and Epilepsy". GeneReviews. University of Washington, Seattle. PMID 27683935.
- ^ Platzer K, Lemke JR (2018). "GRIN1-Related Neurodevelopmental Disorder". GeneReviews. University of Washington, Seattle. PMID 27683935.
- ^ Tsuchida N, Hamada K, Shiina M, Kato M, Kobayashi Y, Tohyama J, et al. (2018). "GRIN2D variants in three cases of developmental and epileptic encephalopathy". Clin Genet. 94 (6): 538–547. doi:10.1111/cge.13454. PMID 30280376. S2CID 52911522.
- ^ Hansen KB, Yi F, Perszyk RE, Furukawa H, Wollmuth LP, Gibb AJ, et al. (2018). "Structure, function, and allosteric modulation of NMDA receptors". J Gen Physiol. 150 (8): 1081–1105. doi:10.1085/jgp.201812032. PMC 6080888. PMID 30037851.
- ^ Grand T, Abi Gerges S, David M, Diana MA, Paoletti P (2018). "Unmasking GluN1/GluN3A excitatory glycine NMDA receptors". Nat Commun. 9 (1): 4769. Bibcode:2018NatCo...9.4769G. doi:10.1038/s41467-018-07236-4. PMC 6233196. PMID 30425244.
- ^ XiangWei W, Jiang Y, Yuan H (2018). "De Novo Mutations and Rare Variants Occurring in NMDA Receptors". Curr Opin Physiol. 2: 27–35. doi:10.1016/j.cophys.2017.12.013. PMC 5945193. PMID 29756080.